Status:

COMPLETED

Omega 3 Fish Oil Supplements vs. Placebo for Patients With Non-alcoholic Steatohepatitis (NASH)

Lead Sponsor:

University of Virginia

Collaborating Sponsors:

National Center for Complementary and Integrative Health (NCCIH)

Conditions:

Non-alcoholic Steatohepatitis

Fatty Liver

Eligibility:

All Genders

21+ years

Phase:

PHASE2

PHASE3

Brief Summary

Nonalcoholic steatohepatitis (NASH) occurs in 2-3% of the US population and carries a 15-20% chance of progression to cirrhosis. It is closely associated with obesity, hyperlipidemia and insulin resis...

Eligibility Criteria

Inclusion

  • NASH with NAS (NASH Activity Score) of \>4 evident on a biopsy performed within 6 months of enrollment.
  • Age 21 years or older.
  • BMI 25 or greater.
  • Ability to provide informed consent.

Exclusion

  • Cirrhosis evident clinically or on biopsy.
  • Secondary forms of NASH such as that seen with bariatric surgery or medication induced from such medications as methotrexate, amiodarone, tamoxifen, corticosteroids.
  • Current or past history of diabetes or hyperlipidemia requiring specific drug therapy (see below).
  • Current use of a weight loss medicine, such as a 'fat-burner' or similar agent
  • Alcohol consumption \> 30 g/day, currently or for more than 3 consecutive months within 5 years.
  • Other liver disease (hepatitis C,B, Wilson's, autoimmune, ct-1-antitrypsin and hemochromatosis or HIV
  • Pregnancy or unwillingness to use an effective form of birth control for women of child bearing years.
  • Renal insufficiency (creatinine \> 2), symptomatic coronary, peripheral or neurovascular disease, symptomatic heart failure or advanced respiratory disease requiring oxygen therapy.
  • Inability to provide informed consent.
  • Any condition in the opinion of the primary investigator that would contraindicate the patient's participation.

Key Trial Info

Start Date :

March 1 2007

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

August 1 2010

Estimated Enrollment :

41 Patients enrolled

Trial Details

Trial ID

NCT00681408

Start Date

March 1 2007

End Date

August 1 2010

Last Update

May 29 2015

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

University of Virginia School of Medicine

Charlottesville, Virginia, United States, 22908